Robert Foster

The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016.

Alberta Economic Development Authority is a non profit organization that provides an independent voice on economic issues that matter to Albertans. The company was founded in 1994 and is headquartered in Calgary, Canada.

Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.

Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.

BioAlberta is a private, not-for-profit industry association that represents and promotes the life sciences industry in Alberta, Canada. The non-profit company is based in Edmonton, Canada. With over 230 members, BioAlberta facilitates economic diversification, investment attraction, and job growth in specialized sectors such as pharmaceuticals, medical devices, natural health products, as well as environmental, agricultural, and industrial biotechnology. The organization provides networking and educational events, and delivers policy options to governments. BioAlberta's activities are focused on advocacy, promotion, marketing, and networking, and industry development. The CEO of the Canadian company is Robb Stoddard.

Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA.